Skip to main content

Animations

MJFF Publications

4941 - 4950 of 6456 Results
Title
Year
  • Year
  • 2025
  • 2025
  • 2021
  • 2019
  • 2018
  • 2021
  • 2021
  • 2023
  • 2021
  • 2020
  • Summary Details
    OPEN
    Title: Long-read sequencing identifies FGF14 repeat expansions in Parkinson’s disease
    Journal Name: Brain
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1093/brain/awaf456
    Citation Count: 1
  • Summary Details
    OPEN
    Title: Long read sequencing reveals transgene concatemerization and vector sequences integration following AAV-driven electroporation of CRISPR RNP complexes in mouse zygotes
    Journal Name: Frontiers in Genome Editing
    Publisher: Frontiers Media SA
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3389/fgeed.2025.1582097
    Citation Count: 8
  • Summary Details
    OPEN
    Title: Accelerating Medicines Partnership: Parkinson's Disease. Genetic Resource
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1002/mds.28549
    Citation Count: 128
  • Summary Details
    OPEN
    Title: Transportation innovation to aid Parkinson disease trial recruitment
    Journal Name: Contemporary Clinical Trials Communications
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.conctc.2019.100449
    Citation Count: 10
  • Summary Details
    OPEN
    Title: Impact of motor fluctuations on real-life gait in Parkinson’s patients
    Journal Name: Gait & Posture
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.gaitpost.2018.03.045
    Citation Count: 33
  • Summary Details
    OPEN
    Title: R1441G but not G2019S mutation enhances LRRK2 mediated Rab10 phosphorylation in human peripheral blood neutrophils
    Journal Name: Acta Neuropathologica
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1007/s00401-021-02325-z
    Citation Count: 84
  • Summary Details
    OPEN
    Title: Urinary proteome profiling for stratifying patients with familial Parkinson’s disease
    Journal Name: EMBO Molecular Medicine
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.15252/emmm.202013257
    Citation Count: 167
  • Summary Details
    OPEN
    Title: Use of Bayesian decision analysis to maximize value in patient-centered randomized clinical trials in Parkinson’s disease
    Journal Name: Journal of Biopharmaceutical Statistics
    Publisher: Informa UK Limited
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1080/10543406.2023.2170400
    Citation Count: 8
  • Summary Details
    OPEN
    Title: Glucosylceramide in cerebrospinal fluid of patients with GBA-associated and idiopathic Parkinson’s disease enrolled in PPMI
    Journal Name: npj Parkinson's Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41531-021-00241-3
    Citation Count: 55
  • Summary Details
    OPEN
    Title: Role of data measurement characteristics in the accurate detection of Parkinson’s disease symptoms using wearable sensors
    Journal Name: Journal of NeuroEngineering and Rehabilitation
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1186/s12984-020-00684-4
    Citation Count: 103
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.